ClinicalTrials.govpublic full text
Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients
cardiorenal syndrome, chronic allograft nephropathy, stem-progenitor cells, calcitriol, paricalcitol, cholecalciferol, cardiac repair, renal repair, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811356
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.